Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cuba claims magnetotherapy success for PID (pelvic inflammatory disease):

This article was originally published in Clinica

Executive Summary

Cuba could soon be using magnetotherapy to treat pelvic inflammatory disease (PID) across the national health system, following positive results from a trial of a "local magnetic stimulator" developed by the national applied electromagnetism centre (CNEA). A study of some 300 women treated with the NAK-02 device in combination with a pharmacological regime is said to have shown "greater curative effect (a rapid reduction in pain, fever and other discomfort), in less time and without adverse reactions" than alternative regimens. The Santiago de Cuba-based CNEA's device was trialled at the city's Hospital Materno Tamara Bunke, in a project headed by Dr Carlos Corral. An estimated 70% of Cuban women of fertile age are said to have had some form of PID. Cuba has the manufacturing capacity to meet national demand for the device, according to the ACN news agency.

You may also be interested in...



Could Eledon’s Anti-CD40L Change Transplant Medicine?

Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation. 

Turning That Frown Upside Down: Treating Depression With Facial Botox Injections

In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049340

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel